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Quality of life (QoL) has become an important issue after early gastric cancer (eGc) treatment. We 
aimed to compare the QoL of eGc survivors after eSD (n = 241) or laparoscopic subtotal gastrectomy 
(n = 241) without recurrence and to evaluate the QoL over the 5-year period after adjusting for various 
confounding factors related to QoL. QoL related to the gastric cancer subscale (GCS) was significantly 
higher in the eSD group than surgery group (p < 0.001). After adjusting for all possible confounding 
factors, survivors who underwent eSD still had higher QoL related to cSG than those who underwent 
surgery. On the analysis of interaction effects for all QoL subscales, higher QoL related to GCS of ESD 
group than those of surgery group has been kept over time (p = 0.983). Therefore, we concluded that 
EGC survivors who undergo ESD have significantly better QoL related to GCS over a 5-year period 
after treatment than those who undergo surgery. this may be a useful consideration when selecting 
treatment modalities for patients with eGc.
Based on the 2015 nationwide cancer statistics, gastric cancer (GC) is the most prevalent type of cancer and is 
the fourth most common cause of cancer mortality in Korea1. On implementation of GC screening as part of the 
National Cancer Screening Program in 1999, screening rates of GC have increased from 7.5% in 2002 to 47.3% 
in 20122. Up to 75% of total GC had early gastric cancers (EGCs). Similarly, the proportion of EGCs treated with 
surgery has increased over time, accounting for 61% of all GCs in 2014 based on a nationwide surgery database3. 
High 5-year survival rates and increased long-term survival of patients with EGCs have led to concerns about 
the quality of life after the complete cure of EGCs. Maintaining gastric function, minimizing post-operative com-
plications, and maximized improvements of quality of life (QoL) have become important issues related with 
surgery. Recently, minimally invasive surgical approaches and function-preserving surgeries are commonly per-
formed in patients with EGCs. The total laparoscopic approach, which is one of the minimally invasive surgical 
approaches, ranked first according to the nationwide data of surgery in 20143. Function-preserving gastrectomy, 
both pyloric-preserving gastrectomy and proximal gastrectomy have been performed with curative intent in 
patients with EGCs4. However, in spite of these efforts, patients who inevitably undergo surgical resection would 
face certain limitations of overall gastrointestinal function. A lot of sequelae, such as early satiety, loss of appetite, 
heartburn, dysphagia, nausea, vomiting, dumping syndrome, and weight loss have a profound impact on QoL in 
these patients5.
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In contrast, the role of endoscopic submucosal dissection (ESD) in EGC patients at low risk for lymph node 
metastasis also has been steadily increasing. Many western studies comparing ESD to surgery have reported 
comparable oncological safety and efficacy in cases of clear resection of EGCs, with low rates of procedure-related 
complications, high cure rates, and extremely infrequent metastatic recurrence, even in elderly patients with 
the poor general condition6–9. With these outstanding short and long-term outcomes of ESD, it is becoming an 
acceptable treatment for EGCs in patients with specific indications. If oncological outcomes do not differ between 
ESD and surgery, treatment option to achieve better QoL should be selected for EGC patients. So far, only two 
studies have compared the difference of QoL between ESD and surgery: One cross-sectional study demonstrated 
a better QoL related to symptomatic and gastrointestinal function in the ESD group10. The other study with the 
follow-up of 24 months after each treatment demonstrated that ESD can provide better QoL in terms of physical 
functioning, body image, and stomach itself symptomatic problem11. However, these studies didn’t demonstrate 
whether the superior QoL would be sustained or would disappear over time. In addition, they didn’t consider 
various confounding factors impacting QoL.
Previous research has suggested that psychological personality factors substantially affect well-being and have 
positive or negative impacts on disease recovery in patients, and may lead to impaired QoL and mental health 
status12–14. Cardiac patients with high levels of anxiety, depression, and lower levels of satisfaction with life have 
poor psychological well-being13. Cancer survivors with Type D personality rather than non-type D personality 
had more pain and general discomfort12,14. While poor sleep quality, insomnia, and inadequate sleep time reduced 
the QoL15, high degrees of resilience contributed to a good QoL in cancer survivors16.
We aimed to demonstrate whether EGC survivors who underwent ESD have a superior QoL compared to 
those who underwent surgery, after adjusting for various confounding factors including socio-demographic char-
acteristics and psychological factors that could influence the QoL. Second, we evaluated whether the QoL differ-
ences between the two groups would remain over time.
Results
Study population characteristics. Baseline characteristics of the study population are summarized in 
Table 1. Mean ages of ESD group at both enrollment and treatment time point were older than the surgery group 
(both p < 0.001). The proportion of men and women was not different in both groups.
Tumor characteristics differed between the groups. The EGC group that underwent ESD had tumors with 
mostly differentiated histology (p < 0.001), smaller size (p < 0.001), and less deep invasion (p < 0.001), resulting 





(n = 241) P value
Age (years), mean ± SD
   At enrollment 64.4 ± 9.2 58.2 ± 10.8 <0.001
   At treatment 62.2 ± 9.4 55.7 ± 10.9 <0.001
Sex, n (%) 0.565
   Men 162 (67.2) 155 (64.3)
   Women 79 (32.8) 86 (35.7)
Histology, n (%) <0.001
   Differentiated 228 (94.6) 108 (44.8)
   Undifferentiated 13 (5.4) 133 (55.2)
Tumor size (mm) 15.6 ± 12.8 23.9 ± 16.1 <0.001
Invasion depth, n (%) <0.001
   Mucosa 225 (93.4) 163 (67.6)
   Submucosal 16 (6.6) 78 (32.4)
Adverse event after treatment, n (%) 0.015a
   Early 16 (6.6) 5 (2.1)
   Late 1 (0.4) 0
Elapse time since ESD or surgery, mean 
± SD (year) 2.1 ± 1.5 2.5 ± 1.6 0.011
   3 month–1 year, n (%) 76 (31.5) 68 (28.2) 0.274
   1–2 years, n (%) 52 (21.6) 39 (16.2)
   2–3 years, n (%) 42 (17.4) 43 (17.8)
   3–4 years, n (%) 40 (16.6) 47 (19.5)
   4–5 years, n (%) 31 (12.9) 44 (18.3)
Resection type
   Distal gastrectomy — 238 (98.8)
   Proximal gastrectomy — 3 (1.2)
Table 1. Baseline characteristics between ESD and surgery groups. aP for Fisher’s exact test.
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Early adverse events after treatment were more frequently reported in the ESD group: post-ESD bleeding 
(n = 12) was most frequent, followed by micro-perforation (n = 3) and electrocoagulation syndrome (n = 1). The 
surgery group had experienced 5 early adverse events; namely, anastomotic leakage (n = 1), postoperative pneu-
monia (n = 1), postoperative fever (n = 1), acute renal failure (n = 1), and severe postoperative nausea and vom-
iting (n = 1). In addition, there was one late adverse event of pyloric stenosis after ESD. However, no late adverse 
event was reported in the surgery group.
Classified by elapsed time (per year) since ESD or surgery, there were no differences in the proportions of the 
study population between ESD and surgery groups (p = 0.274). However, the mean elapsed time of the ESD group 
was shorter than the surgery group (p = 0.011).
With respect to socioeconomic and general health status, both groups showed approximately even distribu-
tion of the employment status, living with a partner, religion, income, current smoking, and family history of GC, 
as shown in Table 2. However, the surgery group had a higher education level (p = 0.003), fewer alcohol drinking 
(p = 0.010), and fewer co-morbidities (p < 0.001), but also a poorer ECOG performance status at the time of 
enrollment (p < 0.001) than the ESD group.
There were significant differences in Distress Thermometer and Cancer Worry Scale scores between the two 
groups (Table 3). The surgery group had a higher Distress Thermometer scale score (p = 0.016). However, there 
was no significant difference of clinically significant distress level (p = 0.162). Patients who underwent ESD 
reported that their physicians, during their medical appointments, seem to worry about the recurrence of their 
cancer (p = 0.049). However, there were no differences between the groups with regard to general worry about 
cancer by themselves, cancer-related concerns, symptoms, and overall scores for worry about cancer recurrence. 
In addition, no significant differences between groups were observed for the HADS, Type D personality scale, 




(n = 241) P value
Employment, n (%) 0.141a
   Full or part-time 115 (47.7) 125 (51.9)
   Unemployed 70 (29.1) 52 (21.6)
   Housewife 56 (23.2) 62 (25.7)
   Student 0 2 (0.8)
Living with partner, n (%) 0.180
   Yes 77 (73.3) 63 (63.6)
   No 28 (26.7) 36 (36.4)
Religion, n (%) 0.521
   Present 130 (53.9) 138 (57.3)
   Absent 111 (46.1) 103 (42.7)
Education level, n (%) 0.003
   Middle school graduate or below 110 (45.6) 74 (30.7)
   High school graduate 82 (34.0) 103 (42.7)
   College graduates or above 49 (20.3) 64 (26.6)
Income (KRW) C 0.465
   <200 100 (41.5) 87 (36.1)
   200–400 98 (40.7) 109 (45.2)
   >400 43 (17.8) 45 (18.7)
Current smoking, n (%) 38 (15.8) 28 (11.6) 0.233
Alcohol drinking, n (%) 86 (35.7) 59 (24.5) 0.010
Current EGOC performance status <0.001
   1 213 (88.4) 175 (72.6)
   ≥2 28 (11.6) 66 (27.4)
Number of co-morbidities, median 
(min-max)b
   0 107 (44.4) 164 (68.1) <0.001
   1 87 (36.1) 55 (22.8)
   ≥2 47 (19.5) 22 (9.1)
Family history of gastric cancer, n (%) 69 (28.6) 78 (32.4) 0.429
Table 2. Socioeconomic and general health status between ESD and surgery groups. aP for Fisher’s exact 
test. bIncluded hypertension, diabetes mellitus, cardiovascular disease (congestive heart disease, ischemic 
heart disease, heart failure), chronic liver disease (liver cirrhosis, choric, renal disease, psychologic disorders, 
pulmonary disease, thyroid function disorders, joint disease (arthritis, rheumatism), sleep disorders, or self-
reported chronic diseases.
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Quality of life comparison between the eSD and surgery groups. The results shown in Table 4 
demonstrate the QoL comparison between the ESD and surgery groups by univariate analyses and ANCOVA 
adjusted for confounders.
In the univariate analyses, ESD groups had higher scores of PWB (p = 0.029) and GCS (p < 0.001). Also, 
FACT-Ga total (p = 0.035), which is the aggregate of PWB, SWB, EWB, FWB, and GCS scores, were also higher 
in the ESD group.
To rule out the possibility of effect of confounder factors, ANCOVA was performed in Model 1 (adjusted for 
age at enrollment and sex) and Model 2 (adjusted for age at enrollment, sex, years since treatment, education 
level, alcohol drinking, current EGOC performance status, number of co-morbidities, Distress Thermometer, 
and doctors’ recurrence worry in Cancer Worry Scale). In ANCOVA Model 1, PWB (p = 0.011), GCS (p < 0.001), 
and FACT-Ga total score (p = 0.029) remained significant after adjustment for age and sex. In ANCOVA Model 2, 
after adjustment for all possible confounding factors, only QoL related to the GCS was significantly higher in the 
ESD group (p < 0.001). There was no difference in QoL related to PWB, SWB, EWB, and FWB after adjustment 
for confounding factors.
Difference of quality of life according to the elapsed time after ESD or surgery.  To test whether 
higher QoL related to GCS changes over time between ESD and surgery groups, we used the Time × Group 




(n = 241) P value
HADS
   Anxiety 2.5 ± 3.0 (1.0) 2.8 ± 3.2 (2.0) 0.258
   Depression 3.2 ± 3.4 (2.0) 3.7 ± 3.4 (3.0) 0.162
Distress thermometer 1.6 ± 2.0 (1.0) 2.1 ± 2.5 (1.0) 0.016
   >4 202 (83.8) 189 (78.4) 0.162
   ≤4 39 (16.2) 52 (21.6)
Type D personality scale
   Negative affectivity 4.5 ± 5.2 (3.0) 4.9 ± 5.5 (3.0) 0.343
   Social inhibition 4.8 ± 5.2 (3.0) 5.5 ± 5.2 (4.0) 0.134
Connor-Davidson resilience scale 69.3 ± 18.2 (70.0) 70.8 ± 19.1 (72.0) 0.365
   Pittsburgh sleep quality index 4.6 ± 2.9 (4.0) 4.6 ± 3.1 (4.0) 0.976
Cancer Worry Scale scores
   Patient recur worry 1.9 ± 2.1 (1.0) 1.9 ± 2.1 (1.0) 0.732
   Doctor recur worry 1.8 ± 2.2 (0.0) 1.4 ± 1.9 (0.0) 0.049
   Concern for some months 1.5 ± 1.8 (0.8) 1.5 ± 1.8 (0.8) 0.861
   Symptom 1.4 ± 1.6 (0.8) 1.6 ± 1.7 (1.3) 0.107
   Total score 6.5 ± 6.0 (5.7) 6.3 ± 5.5 (5.3) 0.668
Table 3. Psychometric characteristics between ESD and surgery groups. Abbreviations: HADS, the Hospital 
Anxiety and Depression Scale, which consists of 7 items for the anxiety and 7 items for the depression subscales.
QoL items













mean (95% CI) Surgery group ESD group Surgery group
PWB subscale (7 items) 3.7 ± 0.4 (3.9) 3.6 ± 0.5 (3.8) 0.029 3.7 (3.7–3.8) 3.6 (3.5–3.7) 0.011 3.6 (3.5–3.6) 3.5 (3.5–3.6) 0.385
SWB subscale (7 items) 2.3 ± 0.9 (2.4) 2.3 ± 1.1 (2.3) 0.632 2.3 (2.2–2.5) 2.3 (2.1–2.4) 0.459 2.4 (2.2–2.5) 2.3 (2.1–2.4) 0.421
EWB subscale (6 items) 3.4 ± 0.6 (3.5) 3.3 ± 0.7 (3.5) 0.536 3.3 (3.2–3.4) 3.3 (3.2–3.4) 0.944 3.1 (3.0–3.2) 3.2 (3.1–3.3) 0.282
FWB subscale (7 items) 2.8 ± 0.8 (2.9) 2.8 ± 0.9 (2.9) 0.616 2.8 (2.7–2.9) 2.7 (2.6–2.8) 0.301 2.7 (2.6–2.9) 2.7 (2.6–2.9) 0.901
Gastric cancer subscale 
(19 items) 3.5 ± 0.4 (3.6) 3.3 ± 0.5 (3.5) <0.001 3.5 (3.5–3.6) 3.3 (3.2–3.3) <0.001 3.4 (3.3–3.5) 3.2 (3.1–3.3) <0.001
FACT-Ga total c 15.8 ± 2.1 (16.0) 15.3 ± 2.7 (15.6) 0.035 15.6 (15.3–16) 15.1 (14.8–15.5) 0.029 15.1 (14.8–15.5) 14.9 (14.5–15.3) 0.321
Table 4. Adjusted QoL items between ESD and surgery groups. Abbreviations: QoL, quality of life; SD, 
standard deviations; CI, confidence interval; PWB, physical well being; SWB, social well being; EWB, emotional 
well being; FWB, functional well being; FACT‐G, FACT‐Ga, Functional Assessment of Cancer Therapy‐Gastric 
quality‐of‐life instrument. aANCOVA Model 1 was adjusted by the age at enrollment and sex. bANCOVA Model 
2 was adjusted by age at enrollment, sex, years since treatment, education level, alcohol drinking, current ECOG 
performance status, number of co-morbidities, Distress Thermometer, and doctor’s recurrence worry in Cancer 
Worry Scale. cFACT-Ga total is calculated as the sum of PWB, SWB, EWB, FWB, and Gastric cancer subscale.
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interaction effects after adjusting age at enrollment, sex, education level, alcohol drinking, current ECOG per-
formance status, number of co-morbidities, distress thermometer, and doctor’s recurrence worry. It revealed 
that higher QoL related to GCS of ESD group than those of surgery group has been kept over time (p = 0.983), as 
shown in Fig. 1.
In addition, to test whether comparable QoL related to PWB, SBW, EWB, and FWB in two groups changes 
over time, we performed the Time × Group interaction effects after adjusting the variables listed above. QoL 
related to PWB, SBW, EWB, and FWB between two groups was similar to the surgery group over time (p = 0.410 
for PWB, p = 0.662 for SWB, p = 0.907 for EWB, and p = 0.535 for FWB).
Discussion
Based on the accumulating data on comparable outcomes of ESD and surgery in terms of curability, 5-year sur-
vival rates, and adverse events, ESD is considered an optimal treatment for patients with EGC without risk of 
lymph node metastasis. In addition, the issue has been raised with improving QoL in long-term survivors after 
complete cure of EGCs. Clinicians have reasonably believed that stomach-preserving ESD might be superior to 
surgery in terms of QoL. However, few studies have directly compared patients’ QoL after adjusting for confound-
ing factors to effect on QoL10.
Our findings support that ESD group is associated with better QoL related to the GCS of ESD than those 
of surgery group. For more objective assessment of individuals’ QoL and comparison of QoL between the two 
groups, we considered a wide range of personality factors and personal stressors such as underlying anxiety 
and depression, recent distress, type D personality of negative affectivity and social inhibition, resilience, quality 
of sleep, and worry of cancer recurrence, based on the evidence that these factors could affect QoL. It is well 
known that there is a close relationship between QoL and anxiety, depression, and emotional functioning in can-
cer survivors17. Most cancer patients and survivors experience intense anxiety and depression, which negatively 
affect QoL18. In particular, the prevalence of depression in GC survivors is known to be high even after being 
disease-free19. GCs survivors with depression were approximately 4.5 times more likely to develop insomnia19. 
Distress is particularly associated with poor social-emotional function affecting QoL18. Patients with both Type D 
personality and GC demonstrated increased levels of pain and fatigue affecting functional capacity and impairing 
QoL12. In addition, patients with low resilience have high psychological distress and low mental health-related 
QoL. GC patients who underwent ESD reported feeling that their physicians worry about recurrence of their can-
cer, which was an independent risk factor of poor QoL10. After adjusting for this wide range of personality types 
and personally stressful situations, we conclude that there is a difference in QoL related to the GCS between ESD 
and surgery groups. To the best of our knowledge, our study is the first attempt to compare QoL in EGC survivors 
who underwent either ESD or surgery after adjusting for this broad a spectrum of confounding personality types 
and personally stressful situations.
The GCS demonstrating a clear distinction between the two groups in our study consists of 19 items for assess-
ment of patient-reported general symptoms, gastrointestinal symptoms, and lifestyle changes related to gastroin-
testinal function. In our study, patients who underwent surgery suffered from more severe digestive problems and 
related lifestyle changes than those underwent ESD. This had an intensely negative effect on QoL related to the 
GCS. Although surgery has been considered a preferred treatment with respect to certain treatment outcomes, 
inevitable sequelae such as postoperative weight loss, loss of appetite, dumping syndrome, anemia, gut hormonal 
change, and others occur.
To date, two studies have described QoL in patients who underwent either ESD or surgery10,20. However, those 
investigators used the European Organization for Research and Treatment of Cancer questionnaire, which is 
different from the one we used. In addition, all of the mean elapsed time since treatment in the enrolled subjects 
was also shorter than those in our study (maximum 18 months, 20.6 months). Similar to our results, their anal-
ysis of the surgery group showed more troublesome symptoms and a poorer body image than those of the ESD 
group10,20. However, PWB and FWB was also significantly better in the ESD group, as reported by Kim YI and 
colleagues, which is different from our results20. In our study, univariate analyses showed that PWB in ESD group 
Figure 1. Time × Group interaction effects on QoL related to gastric cancer subscale. It reflected that 
significant difference of QoL related to gastric cancer subscale known through ANCOVA analysis demonstrated 
no discernable change across time (p = 0.983).
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seems to be superior as well. However, PWB didn’t significantly differ between the two groups on multivariate 
analysis after adjusting for a wide variety of variables. The reasons for the differing results among studies might be 
the lack of adjusted variables in QoL analyses and the different lengths of elapsed time since treatment.
We demonstrated that the QoL advantage of ESD over surgery according to the GCS was sustained up to 
5 years post-treatment. Irrespective of either ESD or surgery, previous studies have shown that impaired QoL 
is inevitable immediately after treatment. According to a study of QoL in patients who underwent ESD, global 
health-related QoL and GCS QoL slightly deteriorated immediately after ESD21. In a study involving serial QoL 
assessment of patients who underwent surgical resection, negative impact on QoL typically occurred for at least 
12 postoperative months and subsequently resolved22,23. However, different patterns of QoL recovery have been 
reported after ESD and surgery. Symptom and functional scale scores reportedly deteriorated immediately in 
patients with EGC after ESD, recovered compared with baseline within 6 months of follow-up, and remained 
unchanged thereafter21,24. However, most studies show that treatment-related symptom scores do not fully recover 
compared with baseline after surgical resection11,21. To date, there is only one study involving serial follow-up of 
QoL for 24 months post-treatment20. According to the results of that study, EGC patients who underwent ESD 
demonstrated better PWB and FWB, fewer stomach-related symptoms, and body image-related QoL benefits for 
1 to 2 years post-treatment20. Although the results of our study are not based on longitudinal serial follow-ups, 
an absolute difference in the QoL of patients who underwent ESD compared to that of patients who underwent 
surgery could be confirmed for 3 months to 5 years post-treatment.
This study has some limitations. One weakness was that the cross-sectional study design didn’t allow the 
analysis of repeated measurement of individuals’ QoL over time. Second, selection bias cannot be fully excluded 
despite the consecutive enrollment of eligible subjects. Further study through rigorously designed randomized 
controlled trials is warranted. Second weakness was that patient’s attitude and way of thinking might be influ-
enced their choice of EGC treatment modality, either EGC or surgery. Although the known various confounding 
factors were adjusted in our study, attention must be paid to the interpretation of our study.
Despite these limitations, we conclude that ESD and surgery’s differences in QoL related to GCS exists and 
is maintained over the 5-year postoperative period. Surgeons and clinicians should consider these differences of 
post-procedural QoL in EGC survivors after ESD or surgery if both treatment modalities are available.
Methods
Design and subject recruitment. This was the multicenter cross-sectional study conducted from 
December 2015 to June 2017 at five referral hospitals in the Republic of Korea providing both ESD and laparo-
scopic-assisted gastrectomy for EGC. The patients had undergone either ESD or laparoscopic-assisted gastrec-
tomy according to the physician’s clinical judgment at that time and visited their gastroenterologist or surgeon 
for follow-ups.
Patients were eligible if they were at least 18 years old, the elapsed time was between 3 months and 5 years after 
ESD or laparoscopic-assisted gastrectomy for EGCs, and there was no evidence of recurrence at enrollment. The 
inclusion criteria for the ESD group were as follows: 1) en bloc resection with free vertical and lateral margins, 
and 2) tumor confined to the submucosal layer (<500 μm) without lymphovascular invasion and lymph node 
metastasis. The inclusion criteria for the laparoscopic-assisted gastrectomy (surgery) group were as follows: 1) en 
bloc resection without residual tumor, and 2) tumor confined to the submucosal layer with no lymphovascular 
invasion and no lymph node metastasis on extended D2 lymphadenectomy. Based on the AJCC 8th TNM stage, 
TNM stage of ESD group and surgery group was all stage IA25.
We speculated that up to 3 months after ESD or laparoscopic-assisted gastrectomy, patients would still have 
troublesome treatment-related gastrointestinal symptoms resulting in unstable QoL, and those who didn’t show 
any evidence of recurrence for more than 5 years would have stable QoL. Therefore, we excluded patients who 
were within 3 months of or more than 5 years status-post ESD or laparoscopic-assisted gastrectomy. We also 
excluded patients who underwent total gastrectomy and near total gastrectomy because the loss of reservoir 
function is predictable as the result of inevitable worsening of QoL (Fig. 2).
This study was approved in all participating institutes (Ewha Womans University Mokdong Hospital 
Institutional Review Board, Institutional Review Board of Incheon St. Mary’s Hospital, Yonsei University 
Health System, Severance Hospital, Institutional Review Board, Soonchunhyang University Bucheon Hospital 
Institutional Review Board, Hallym University Chuncheon Sacred Heart Hospital Institutional Review Board, 
Jeju National University Hospital Institude Review Board, Wonkwang University Hospital Institutional Review 
Board, and Institutional Review Board Wonkwang University Sanbon Hospital). All subjects provided informed 
written consent before participating. This study has been carried out in accordance with the Declaration of 
Helsinki.
Data collection. We collected the data of treatment and histopathological characteristics by reviewing the 
institutional database, which contained information about the tumor size (maximal tumor size and invasion 
depth), histological type (‘differentiated’ including well- and moderately-differentiated tubular adenocarcinoma 
and papillary carcinoma, and ‘undifferentiated’ including poorly differentiated adenocarcinoma, mucinous ade-
nocarcinoma, signet ring cell carcinoma, and lymphoepithelioma-like gastric carcinoma), and time to treatment.
Complications were analyzed considering the onset time of complication after treatment. An early adverse 
event was defined as a complication that occurred within 3 months of treatment, while late complications were 
defined as occurring beyond 3 months of treatment. Post-ESD bleeding is defined as hematemesis or melena 
requiring transfusion with clinical evidence ESD-induced ulcer bleeding. The electrocoagulation syndrome is 
clinically defined localized abdominal pain, rebound tenderness, fever > 38 °C, and signs of peritoneal irri-
tation without frank perforation. All ESD-related perforations was divided into a macroperforation and a 
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microperforation. A macroperforation was defined as a gross perforation that occurred during an ESD procedure 
and a microperforation was defined by free air visible on X-rays after the procedure. In surgery group, postopera-
tive fever is defined as a fever > 38 °C on 2 consecutive postoperative days or above 39 °C on any 1 postoperative 
day. Postoperative pneumonia was defined as a newly developed infiltrates on the chest radiograph after surgery. 
In addition, postoperative complications requiring pharmacological treatment or surgical endoscopic radiologic 
interventions were described.
Questionnaires. To collect the socio-demographic status including general health status, psychometric char-
acteristics, and quality of life, we developed a structured self-administrated questionnaire. Concerning to the 
questionnaire, after acquisition written consent of this study, our survey was conducted at the waiting time for 
tests or to see their doctor. To prevent omission error, our researcher repeatedly asked responders to fill in missing 
questions as much as possible. The socio-demographic questionnaire consisted of 12 items; age (at enrollment 
and at treatment), sex, status of employment (full or part-time, unemployed, housewife, or student), living with 
partner (yes or no), religion (present or absent), education level (middle school graduate or below, high school 
graduate, or college graduate or above), income (<200 Korea Won (KRW), 200–400 KRW, > 400 KRW), current 
smoking, alcohol drinking, current Eastern Cooperative Oncology Group (ECOG) performance status, kinds and 
the number of co-morbidities, and family history of gastric cancer (yes or no).
To assess psychometric characteristics, we used the standard questionnaire forms of the Hospital Anxiety and 
Depression Scale (HADS), Distress Thermometer, Type D personality scale, Connor-Davidson resilience scale, 
Pittsburgh sleep quality index, and Cancer Worry Scale.
HADS is a frequently used tool to assess psychological distress, which consists of 7 items for the anxiety and 
7 items for the depression subscales26. The score was interpreted as normal, 0–7 points; borderline, 8–10 points; 
and abnormal, 11–21 points27. Internal consistency measured by Cronbach’s alpha of the HADS Korean version 
was reported as 0.89 for anxiety and 0.86 for depression28.
The Distress Thermometer consists of single item asking subjects to rate their distress in the past week using 
a visual analog scale. Developed by the National Comprehensive Cancer Network, it is an effective screening 
tool for detecting distress among patients with various diseases, such as cancer. They suggests that a score of 4 or 
higher on the Distress Thermometer indicates a clinically significant distress level29.
We used the 14-item Type D personality scale to assess for distressed personality. It consists of 7 items on neg-
ative affectivity and 7 items on social inhibition. Patients were categorized as Type D personality using a stand-
ardized cutoff score of ≥10 on both the negative affectivity and social inhibition subscales30. Internal consistency, 
measured by Cronbach’s alpha, was 0.86 for negative affectivity and 0.90 for social inhibition31.
To measure resilience, we used the Korean version of the 25-item Connor-Davidson resilience scale, which 
has good reliability and validity. Each item was rated on a 5-point Linkert scale from 0 (not true at all) to 4 (true 
nearly all the time), with higher scores reflecting greater resilience. The reported Cronbach’s alpha values of the 
adapted Korean version was 0.9332.
To measure sleep quality, we used the Pittsburgh sleep quality index, which is a self-rated questionnaire assess-
ing sleep quality and disturbances over a 1-month time interval33. Nineteen items compose 7 components: sleep 
quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, 
and daytime dysfunction33. The Cronbach’s α coefficient for internal consistency was 0.84, which shows high 
reliability34.
To measure worry about cancer recurrence, we used the validated Cancer Worry Scale questionnaire. We 
formally granted permission to use the Functional Assessment of Cancer Therapy – Gastric Cancer (FACT-Ga) 
by the copyright owner. It contains 13 items measuring 4 subjective aspects of worry: judged risk of cancer, worry 
about cancer recurrence, general worry about cancer over the previous months, and symptom level. A higher 
score indicates a greater concern about cancer recurrence. In our study, the Cronbach’s alpha value of the adapted 
Korean version was 0.90.
QoL was assessed using the Korean Version of FACT-Ga, version 4. We formally granted permission to use the 
FACT-Ga by the copyright owner. FACT-Ga has developed as a GC-specific instrument to evaluate the patients’ 
QoL. FACT-Ga consists of FACT-G (28 items) and a gastric cancer subscale (GCS, 19 items). FACT-G comprises 
Figure 2. Flow diagram of enrolled participation.
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four general subscales: physical well-being (PWB, 28 items), social well-being (SWB, 28 items), emotional 
well-being (EWB, 24 items), and functional well-being (FWB, 28 items). GCS consists of 19 items for assessment 
of patient-reported general symptoms (4 items; weakness, fatigue, loss of weight, and loss of appetite), gastroin-
testinal symptoms (8 items: trouble swallowing, reflux or heartburn, abdominal pain or discomfort in the stom-
ach area, pain or discomfort while eating, fullness or heaviness in the stomach area, swelling or cramping in the 
stomach area, diarrhea, and gas or flatulence), and lifestyle changes related to gastrointestinal function (7 items; 
change of eating habits, enjoying meals with family or friends, eating favorite foods, avoidance of eating-out, 
interference with usual activities, worry about stomach problems, difficulty in planning for the future due to 
illness). The aggregate of PWB, SWB, EWB, FWB, and GCS scores is the FACT-Ga total. Therefore, the higher 
score of FACT-Ga could be reflecting higher QoL. The internal consistency of each subscale was tested by calcu-
lating the Cronbach’s alpha coefficients. In our study, all subscales demonstrated good internal consistency with 
α > 0.8 (0.897, 0.884, 0.887, 0.875, 0.894, and 0.854; Cronbach’s alpha coefficients of PWB, SWB, EWB, FWB, 
GCS, and FACT-Ga total, respectively).
Sample size calculation. For recruitment of enough subjects to achieve sufficient statistical power, we cal-
culated the sample size based on the previous study of the comparison of QoL between ESD and gastrectomy 
groups using G*Power Version 3.0.10 software program (Franz Fual, University of Kiel, Germany)10. With the 
total sample size of 434 subjects (217 subjects in each group), we would achieve the 80% power at the 0.05 signif-
icance level to detect a mean difference of 0.5 points in QoL between the ESD and gastrectomy groups, assuming 
that QoL would be higher in the patients with ESD group. Considering the dropout rate of 10%, a total of 482 
subjects (241 subjects per each group) would be needed to detect significant outcomes.
Statistical analyses. In the comparison of all variables between the ESD and surgery groups, continuous 
values were presented as means ± standard deviations, while categorical variables were shown as proportions. 
Statistical differences were determined using the t-test and chi-square test for continuous and categorical varia-
bles, respectively.
We performed an analysis of covariance (ANCOVA) to investigate whether there are significant differences 
in the QoL subscale scores between the two groups after adjusting for various variables and factors. ANCOVA 
Model 1 was adjusted by the age at enrollment and sex. ANCOVA Model 2 was adjusted by age at enrollment, 
sex, years since treatment, education level, alcohol drinking, current ECOG performance status, number of 
co-morbidities, Distress Thermometer, and doctors’ recurrence worry in Cancer Worry Scale. All factors used 
for adjustment in Model 2 met p value < 0.1 in the univariate analyses. Prior to modeling, we confirmed that the 
variance inflation factor values of these variables were less than 2. We reported the results as least square means 
with 95% confidence interval (CI) in ANCOVA Models 1 and 2. Additionally, we tested the elapsed time × group 
interaction to determine whether the QoL’s difference of GCS between two groups constantly continues over time.
Statistical analyses were performed using SPSS ver. 20.0 for Windows (SPSS Inc., Chicago, IL, USA), and p 
values < 0.05 were considered statistically significant.
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